Anthrax, an infectious disease caused by the bacterium Bacillus anthracis, is often treatable in its early stages. But once ...

The antibiotic teixobactin—developed a decade ago by Northeastern University professors Kim Lewis and Slava Epstein in collaboration with university startup NovoBiotic—has already proven itself ...

Anthrax, otherwise known as the bacterium Bacillus anthracis, is a deadly serious infectious disease that kills without question if its toxins reach a host's cells. A new treatment developed by ...

University of Pittsburgh researchers discovered that a mix of growth factors can rescue cells from late-stage anthrax damage ...

Anthrax, an infectious disease caused by the bacterium Bacillus anthracis, is often treatable in its early stages. But once ...

Results provide proof-of-concept that ERK pathway reactivation might be an effective, biologically based therapy to prevent anthrax-induced lethality.

WE RECENTLY reported on the use of aureomycin in the treatment of two cases of anthrax. 1 We now wish to record our experience with eight additional cases that were successfully treated with the ...

Because different types of cells in the body may require different growth factors to activate ERK, the researchers are now working to optimize a treatment for anthrax in humans. Other authors on ...